Virtual Clinical Trials Market
Report ID: SQMIG35D2037
Report ID: SQMIG35D2037
sales@skyquestt.com
USA +1 351-333-4748
Report ID:
SQMIG35D2037 |
Region:
Global |
Published Date: December, 2025
Pages:
219
|Tables:
63
|Figures:
75
Global Virtual Clinical Trials Market size was valued at USD 9.9 billion in 2024 and is poised to grow from USD 10.53 billion in 2025 to USD 17.3 billion by 2033, growing at a CAGR of 6.4% during the forecast period (2026-2033).
The increasing digitization of healthcare infrastructure worldwide is one of the primary reasons driving market growth. Increased use of VCT for dermatology testing is driving market expansion. Remote trials are commonly used to evaluate skin problems that do not require complex examinations. As the coronavirus disease (COVID-19) continues to spread worldwide, there has been a significant increase in demand for virtual and remote testing solutions for safe and effective data collection. Furthermore, technical innovations such as the launch of virtual patient interaction platforms and the utilization of wearable technologies are contributing as growth drivers. Through telemedicine platforms, these technologies assist in connecting patients with treating clinicians. Also, the absence of guidelines and the need to add information arising from the massive flow of information may hamper the market growth.
US Virtual Clinical Trials Market is poised to grow at a sustainable CAGR for the next forecast year.
Market snapshot - 2026-2033
Global Market Size
USD 9.3 billion
Largest Segment
Oncology
Fastest Growth
Cardiovascular
Growth Rate
6.4% CAGR
To get more insights on this market click here to Request a Free Sample Report
Global Virtual Clinical Trials Market is segmented by Type of Study, Mode of Virtual Clinical Trial, Therapeutic Area, Clinical Trial Phase, Company Size, End-User and region. Based on Type of Study, the market is segmented into Interventional Study and Observational Study. Based on Mode of Virtual Clinical Trial, the market is segmented into Hybrid Clinical Trials and Fully Virtual Clinical Trials. Based on Therapeutic Area, the market is segmented into Oncological Disorders, Rare Disorders, Infectious Diseases, Neurological Disorders, Respiratory Disorders, Cardiovascular Disorders and Other Disorders. Based on Clinical Trial Phase, the market is segmented into Phase IV, Phase III, Phase II and Phase I. Based on Company Size, the market is segmented into Large Companies, Mid-sized Companies and Small Companies. Based on End-User, the market is segmented into Pharmaceutical and Biotechnology Companies, Clinical Research Organizations, Academic and Research Institutes and Other End-users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
On the basis of indication, global virtual clinical trials market is segmented into oncology, cardiovascular, and other. The oncology segment dominated the global market. This is due to the increasing number of cancer cases globally and the increasing number of oncology clinical trials. Cancer patients are most vulnerable during the Covid-19 pandemic. Oncology clinical trial investigators and sponsors have quickly adopted virtual and remote trials to keep patients safe and trials moving forward.
On the basis of study design, global virtual clinical trials market is segmented into, Interventional, observational and expanded access. The interventional design segment dominated the virtual clinical trials market. The rapid increase in the number of experiments and digitization of laboratories to develop new drugs for various diseases are the driving factors for this segment. The coronavirus outbreak has increased the demand for trials and testing of new drugs and vaccines to deal with the situation around the world as the traditional method of clinical trials carries a high risk of infecting people.
To get detailed segments analysis, Request a Free Sample Report
On the basis of region, global virtual clinical trials market is divided into North America, Europe, Asia Pacific, Latin America, and MEA. North America dominated the global virtual clinical trials market. This is due to increasing R&D in the region, increased adoption of new technologies in clinical research, and government support. Also, market players are using digital technology to meet the needs of consumers. For example, Parexel conducted more than 100 decentralized tests with hybrid and virtual techniques. Covance also operates about 1,900 LabCorp Patient Service Centres across the United States, bringing testing to patients.
Asia Pacific is expected to grow at the fastest CAGR during the forecast period due to the increasing availability of a large patient, easy recruitment of candidates, and enhanced access to digital technology in the region. Also, the outbreak of coronavirus is expected to boost the adoption of telemedicine, thus boosting the market in the region. Japan was the largest market in the Asia Pacific due to high healthcare and R&D expenditures and growing demand for virtual clinical trials in the market.
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Real-time reporting and data collection
Greater patient reach and reduced costs
Concerns over data accuracy and security
Request Free Customization of this report to help us to meet your business objectives.
Global virtual clinical trials market is highly competitive with the presence of local as well as global companies. The major players are adopting several growth strategies such as product launches, acquisitions, and collaborations, which are contributing to the growth of global market.
SkyQuest's ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our business information services team that collects, collates, co-relates, and analyses the data collected by means of primary exploratory research backed by the robust secondary desk research.
According to our global virtual clinical trials market analysis, the global market is dominated by the oncology segment. This is due to the increasing number of cancer cases globally and the increasing number of oncology clinical trials. By region, North America dominates the global market and accounts for the largest revenue share of 49.2%. This is due to increasing R&D in the region, increased adoption of new technologies in clinical research as well as government support.
| Report Metric | Details |
|---|---|
| Market size value in 2024 | USD 9.9 billion |
| Market size value in 2033 | USD 17.3 billion |
| Growth Rate | 6.4% |
| Base year | 2024 |
| Forecast period | 2026-2033 |
| Forecast Unit (Value) | USD Billion |
| Segments covered |
|
| Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
| Companies covered |
|
| Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Table Of Content
Executive Summary
Market overview
Parent Market Analysis
Market overview
Market size
KEY MARKET INSIGHTS
COVID IMPACT
MARKET DYNAMICS & OUTLOOK
Market Size by Region
KEY COMPANY PROFILES
Methodology
For the Virtual Clinical Trials Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Virtual Clinical Trials Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Virtual Clinical Trials Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Virtual Clinical Trials Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
REQUEST FOR SAMPLE
REQUEST FREE CUSTOMIZATION
Global Virtual Clinical Trials Market size was valued at USD 9.9 Billion in 2024 and is poised to grow from USD 10.53 Billion in 2025 to USD 17.3 Billion by 2033, growing at a CAGR of 6.4% during the forecast period (2026–2033).
Global virtual clinical trials market is highly competitive with the presence of local as well as global companies. The major players are adopting several growth strategies such as product launches, acquisitions, and collaborations, which are contributing to the growth of global market. 'IQVIA (USA) ', 'ICON plc (Ireland) ', 'Parexel International (USA) ', 'Charles River Laboratories (USA) ', 'Medidata Solutions (USA) ', 'Oracle Health (USA) ', 'PRA Health Sciences (USA) ', 'Pharmaleads (USA) ', 'Medpace (USA) ', 'Certara (USA) ', 'Syntract (USA) ', 'Velocity Clinical Research (USA) ', 'INC Research (USA) '
Real time reporting and data collection is a major factor drives the market growth. The majority of data is transferred from smartphone or wearable directly into the clinical database, rather than relying on clinical trial staff to transfer data from various documents into the clinical trial database where data can potentially be lost or edited by mistake. A diverse range of participants makes the data richer and of higher quality.
A virtual clinical trial is an alternative method to traditional clinical trial. New connected devices empower clinical trial activities with better clinical data collection, analysis, and interpretation. Clinical trial monitoring devices, clinical trial software, eCOA, ePRO, and eConsent are some of the digital tools that increase clinical trial activities. The bring-your-own-devices strategy is a key trend widely accepted among CROs and sponsors. This new strategy allows test participants to deliver the required data with their own Internet-enabled solutions. Technological progress and confidence in improved research results can lead to new solutions. A recent retrospective approach using a synthetic clinical trial approach provides significant clinical development. This is a new approach in the virtual clinical trials market and is expected to grow significantly. Also, the involvement of artificial intelligence (AI) in clinical trials significantly changes the trial process as AI can speed up target validation, clinical trial design, and patient identification to participate in virtual clinical trials.
On the basis of region, global virtual clinical trials market is divided into North America, Europe, Asia Pacific, Latin America, and MEA. North America dominated the global virtual clinical trials market. This is due to increasing R&D in the region, increased adoption of new technologies in clinical research, and government support. Also, market players are using digital technology to meet the needs of consumers. For example, Parexel conducted more than 100 decentralized tests with hybrid and virtual techniques. Covance also operates about 1,900 LabCorp Patient Service Centres across the United States, bringing testing to patients.
Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Feedback From Our Clients
USA (+1) 351-333-4748
